Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Agents for postmenopausal syndrome in development at Lilly

Oct. 8, 1997

Spine-Tech and Sulzer Orthopedics Biologics announce alliance

Oct. 6, 1997

Mitsui Toatsu's hGH enters clinical testing this month

Oct. 6, 1997

Efficacy of cholesterol biosynthesis inhibitor demonstrated in dogs

Oct. 6, 1997

Safety and efficacy data for INVICORP reported at impotence meeting

Oct. 6, 1997

SS-Cream evaluated in subjects with premature ejaculation

Oct. 6, 1997

Regeneron and P&G joint development program for obesity

Oct. 3, 1997

L-Arginine not associated with objective improvement in organic ED

Oct. 3, 1997

Linsidomine + moxisylyte for ED

Oct. 3, 1997

Effects of BQ-123 and BQ-788 on ET-1-induced corpus cavernosum contractions

Oct. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...